Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies
Clinical trial NCT06561243 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06561243
- Sponsor
- University Hospital, Caen
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-25
- Primary completion
- 2024-09-30
- Enrollment
- 15000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.